Sign in

CIK 0001157601 · Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
Open-market buys, last 90 days
$35,023,032
in 1 filing
Open-market sales, last 90 days
$7,011,938
in 3 filings, $6.7M under 10b5-1 plans

Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. BAKER BROS. ADVISORS LP +$35.0M Director 1 filing
  2. Sibold William John −$6.2M President and CEO sold 6% of stake
  3. Kelley Shannon T −$773K General Counsel sold 14% of stake
Date Insider Transaction Shares Price Value Owned after
2011-07-01 WILSON ROBERT N Director Grant or award · Director Stock Option (Right to Buy) +5,500 5,500
2011-07-01 Gollust Keith R Director Grant or award +3,929 183,452
2011-07-01 Gollust Keith R Director Grant or award +3,929 187,381
2011-07-01 Gollust Keith R Director Grant or award · Director Stock Option (Right to Buy) +5,500 5,500
2011-07-01 Gollust Keith R Director Grant or award · Director Stock Option (Right to Buy) +2,500 2,500
2011-07-01 Kovner Bruce Director Grant or award +7,858 4,765,124
2011-07-01 Kovner Bruce Director Grant or award · Director Stock Option (Right to Buy) +5,500 5,500
2011-04-25 Koya Keizo Sr. VP, Drug Development Sale −10,000 $6.00 $60K 19,843
2011-04-20 Koya Keizo Sr. VP, Drug Development Sale −10,000 $5.60 $56K 29,843
2011-04-14 WILSON ROBERT N Director Purchase +50,000 $4.89 $245K 522,399
2011-04-14 Gollust Keith R Director Purchase +100,000 $4.89 $489K 1,677,967
2011-04-14 Kovner Bruce Director Purchase +1,431,493 $4.89 $7.0M 4,757,266
2011-03-15 Bahcall Safi R President and CEO Purchase +5,000 $4.45 $22K 2,333,135
2011-03-01 Bahcall Safi R President and CEO Grant or award +11,549 2,328,135
2011-03-01 Bahcall Safi R President and CEO Grant or award · Employee Stock Option (Right to Buy) +200,000 200,000
2011-03-01 Vukovic Vojo SVP, Chief Medical Officer Sale −2,617 $5.32 $14K 15,004
2011-03-01 Vukovic Vojo SVP, Chief Medical Officer Grant or award +7,300 22,304
2011-03-01 Vukovic Vojo SVP, Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +100,000 100,000
2011-03-01 Rieder Wendy E VP, IP and Legal, Gen. Counsel Sale −5,284 $5.25 $28K 15,426
2011-03-01 Rieder Wendy E VP, IP and Legal, Gen. Counsel Grant or award +4,397 19,823

Page 74 of 82 · 1,629 trades